– Canada is a key country in the North American medical and companion animal healthcare market, with strong connectivity to the U.S. market. Through its Canadian patent filing, Rebiogen aims to secure intellectual property protection while simultaneously expanding its business footprint across North America.
– Thailand represents a core market in Southeast Asia, where the companion animal population and demand for veterinary healthcare services are rapidly growing. Based on its Thai patent filing, Rebiogen plans to prevent technology imitation and progressively expand partnerships with local veterinary networks and distribution partners.
https://www.mt.co.kr/industry/2025/12/30/2025122917130744752
(Source: MT)